245 related articles for article (PubMed ID: 739057)
1. Failure of factor VIII inhibitor bypassing activity (Feiba) to secure haemostasis in haemophilic patients with antibodies.
Parry DH; Bloom AL
J Clin Pathol; 1978 Nov; 31(11):1102-5. PubMed ID: 739057
[TBL] [Abstract][Full Text] [Related]
2. The effect of activated prothrombin-complex concentrate (FEIBA) on joint and muscle bleeding in patients with hemophilia A and antibodies to factor VIII. A double-blind clinical trial.
Sjamsoedin LJ; Heijnen L; Mauser-Bunschoten EP; van Geijlswijk JL; van Houwelingen H; van Asten P; Sixma JJ
N Engl J Med; 1981 Sep; 305(13):717-21. PubMed ID: 6790990
[TBL] [Abstract][Full Text] [Related]
3. Effects of low-dose 'factor VIII inhibitor bypassing activity (FEIBA)' in resistant haemophilia.
Zwahlen H; Beck EA
Acta Haematol; 1980; 64(1):12-7. PubMed ID: 6774572
[TBL] [Abstract][Full Text] [Related]
4. Multicenter retrospective study on the utilization of FEIBA in France in patients with factor VIII and factor IX inhibitors. French FEIBA Study Group. Factor Eight Bypassing Activity.
Negrier C; Goudemand J; Sultan Y; Bertrand M; Rothschild C; Lauroua P
Thromb Haemost; 1997 Jun; 77(6):1113-9. PubMed ID: 9241742
[TBL] [Abstract][Full Text] [Related]
5. Activated F IX concentrate (FEIBA) used in the treatment of haemophilic patients with antibody to F VIII.
Stenbjerg S; Jørgensen J
Acta Med Scand; 1978; 203(6):471-6. PubMed ID: 665313
[TBL] [Abstract][Full Text] [Related]
6. Resistance to activated F IX concentrate (FEIBA).
Stenbjerg S; Jorgensen J
Scand J Haematol; 1977 May; 18(5):421-6. PubMed ID: 877518
[TBL] [Abstract][Full Text] [Related]
7. [Articular and muscular hemorrhages in hemophilia A with anti-factor VIII antibodies. Treatment with selected batches of PPSB (factor IX concentrate)].
Verroust F; Moussard C; Allain JP
Presse Med; 1985 May; 14(19):1073-6. PubMed ID: 3158962
[TBL] [Abstract][Full Text] [Related]
8. Hemophilia and von Willebrand's disease: 2. Management. Association of Hemophilia Clinic Directors of Canada.
CMAJ; 1995 Jul; 153(2):147-57. PubMed ID: 7600466
[TBL] [Abstract][Full Text] [Related]
9. Comparative efficacy of nonheated and heat-treated factor IX complex concentrate in treatment of hemophiliacs with inhibitors.
Schwartz RS; Ewing NP; Gorenc TJ; Spero JA
Am J Hematol; 1989 Jan; 30(1):22-6. PubMed ID: 2491929
[TBL] [Abstract][Full Text] [Related]
10. Inhibitor antibodies to factor VIII and factor IX: management.
Lusher JM
Semin Thromb Hemost; 2000; 26(2):179-88. PubMed ID: 10919411
[TBL] [Abstract][Full Text] [Related]
11. Laboratory evidence of DIC under FEIBA treatment of a hemophilic patient with intracranial bleeding and high titre factor VIII inhibitor.
Fukui H; Fujimura Y; Takahashi Y; Mikami S; Yoshioka A
Thromb Res; 1981 Apr 1-15; 22(1-2):177-84. PubMed ID: 6794176
[No Abstract] [Full Text] [Related]
12. The use of FEIBA (factor eight inhibitor bypassing activity) in cataract extraction in hemophilia A patient with inhibitor.
Tourbaf KD; Dunlap BE; Ambrus JL; Rodman DJ; Atwal AJ
J Med; 1982; 13(5-6):399-410. PubMed ID: 6820380
[TBL] [Abstract][Full Text] [Related]
13. [Therapy of immuninhibitor hemophilia A with FEIBA plasma fraction].
István L; Bariska I; Marton E
Orv Hetil; 1980 Dec; 121(51):3131-5. PubMed ID: 6784062
[No Abstract] [Full Text] [Related]
14. Extracorporeal immunoadsorption for the treatment of haemophilic patients with inhibitors to factor VIII or IX.
Knöbl P; Derfler K
Vox Sang; 1999; 77 Suppl 1():57-64. PubMed ID: 10529691
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of patients with hemophilia A having antibodies to factor VIII].
Lopaciuk S; Ziemski JM
Acta Haematol Pol; 1979; 10(2):115-22. PubMed ID: 474044
[TBL] [Abstract][Full Text] [Related]
16. FEIBA: mode of action.
Turecek PL; Váradi K; Gritsch H; Schwarz HP
Haemophilia; 2004 Sep; 10 Suppl 2():3-9. PubMed ID: 15385040
[TBL] [Abstract][Full Text] [Related]
17. [Importance of PPSB fraction in the treatment of hemophilia A with antibodies against factor VIII].
Hrubisková K
Folia Haematol Int Mag Klin Morphol Blutforsch; 1980; 107(4):672-82. PubMed ID: 6162735
[TBL] [Abstract][Full Text] [Related]
18. Apheresis.
Nilsson IM; Freiburghaus C
Adv Exp Med Biol; 1995; 386():175-84. PubMed ID: 8851026
[TBL] [Abstract][Full Text] [Related]
19. Letter: Factor-VIII inhibitor bypassing activity.
Pollock A; Lewis MJ
Lancet; 1976 Jul; 2(7975):43-4. PubMed ID: 59103
[No Abstract] [Full Text] [Related]
20. [Treatment of hemophiliacs with inhibitors].
Fujimaki M
Rinsho Ketsueki; 1985 Jul; 26(7):1059-68. PubMed ID: 3932719
[No Abstract] [Full Text] [Related]
[Next] [New Search]
